QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 172 filers reported holding QIAGEN NV in Q4 2014. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $922,000 | -0.8% | 32,901 | -2.8% | 0.03% | -3.2% |
| Q3 2016 | $929,000 | +13.6% | 33,856 | -9.7% | 0.03% | +6.9% |
| Q2 2016 | $818,000 | -0.2% | 37,508 | +2.2% | 0.03% | -3.3% |
| Q1 2016 | $820,000 | -15.2% | 36,694 | +4.9% | 0.03% | -14.3% |
| Q4 2015 | $967,000 | +83.8% | 34,969 | +71.6% | 0.04% | +75.0% |
| Q3 2015 | $526,000 | +3.3% | 20,382 | -0.8% | 0.02% | +17.6% |
| Q2 2015 | $509,000 | -4.0% | 20,550 | -2.4% | 0.02% | -5.6% |
| Q1 2015 | $530,000 | +59.2% | 21,045 | +48.0% | 0.02% | +63.6% |
| Q4 2014 | $333,000 | -31.2% | 14,223 | -33.2% | 0.01% | -31.2% |
| Q3 2014 | $484,000 | +6.4% | 21,287 | +14.3% | 0.02% | +6.7% |
| Q2 2014 | $455,000 | +9.1% | 18,620 | -5.8% | 0.02% | +7.1% |
| Q1 2014 | $417,000 | -17.9% | 19,776 | -7.3% | 0.01% | -17.6% |
| Q4 2013 | $508,000 | +8.8% | 21,332 | -2.3% | 0.02% | 0.0% |
| Q3 2013 | $467,000 | +6.4% | 21,827 | -1.1% | 0.02% | 0.0% |
| Q2 2013 | $439,000 | – | 22,075 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |